Symbols

NRXS

Neuraxis·AMEX

--(--)

NRXS fundamentals

NRXS Q4 2025 Earnings

Neuraxis (NRXS) released its earnings on Mar 19, 2026: revenue was 968.00K (YoY +27.19%), beat estimates; EPS was -0.215 (YoY -4.88%), met estimates.

Revenue / YoY

968.00K

+27.19%

EPS / YoY

-0.215

-4.88%

Report date

Mar 19, 2026

NRXS Earnings Call Summary for Q4,2025

Revenue Surge: Q4 2025 revenue up 27% YoY, Q1 2026 outperforms expectations with 35% unit growth.
Strategic Milestones: Category 1 CPT code adoption drives 10x prior auth submissions, 45M covered lives secured.
Operational Efficiency: Gross margin stabilization expected in 2026, operating expenses growing at half the revenue pace.
Adult Market Breakthrough: Cleveland Clinic RCT underway, VA utilization surpassing expectations.
Liquidity Strength: $6M+ cash, no near-term financing needs.

Earnings

EPS

Revenue

Revenue & Expenses

NRXS has released its 2025 Q4 earnings report, with revenue of 968.13K, reflecting a YoY change of 27.19%, and net profit of -1.71M, showing a YoY change of -18.01%. The Sankey diagram below clearly presents NRXS's revenue sources and cost distribution.

Key Indicators

Neuraxis (NRXS) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Neuraxis (NRXS)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Neuraxis (NRXS)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Neuraxis (NRXS)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown